GlassScriptPhysician profile
Jonathan Luke Arnholt
NPI 1235321993
$3,895.09
in general payments reported to CMS, 2019-2025
19 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $1,207 · 2021: $174 · 2022: $465 · 2023: $477 · 2024: $368 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,564.74 | 2019-2020 | |
| Inspire Medical Systems, INC. | $762.67 | 2019-2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $288.85 | 2021-2025 | Tezspire |
| Medtronic, INC. | $243.00 | 2023-2025 | Ligasure, Propel, Pteye Parathyroid Detection System |
| Optinose US, INC. | $149.03 | 2020-2023 | |
| Genzyme Corporation | $127.89 | 2019-2024 | |
| Acclarent, INC | $123.10 | 2020-2023 | Trudi Nav Cable, Relieva Spinplus |
| Stryker Corporation | $108.25 | 2019-2024 | Audion Et Dilation System |
| Glaxosmithkline, LLC. | $95.07 | 2025 | Nucala |
| Carestream Dental, LLC | $85.74 | 2019 | |
| Intersect Ent, INC. | $79.57 | 2019-2021 | |
| Kaleo, INC. | $55.08 | 2022-2023 | Auvi-Q |
| Novartis Pharmaceuticals Corporation | $42.98 | 2021-2022 | |
| Integra Lifesciences Corporation | $42.31 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Xoran Technologies LLC | $40.82 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.78 | 2019 | |
| Smith+Nephew, INC. | $25.83 | 2024 | Halo |
| Merck Sharp & Dohme LLC | $18.56 | 2023 | |
| Zoll Respicardia, INC. | $13.82 | 2024 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Arnholt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.